Keyphrases
Gemcitabine
60%
Thrombosis
59%
Chemotherapy
59%
Pancreatic Cancer
56%
5-fluorouracil (5-FU)
55%
Tumor
55%
Carcinoma
52%
Phase II Trial
46%
Oxaliplatin
42%
Catheter
42%
Hepatocellular Carcinoma
38%
Low Molecular Weight Heparin
38%
Confidence Interval
37%
Liver
37%
Carbamazepine
36%
Cyclophosphamide
35%
Interferon-γ
35%
Advanced Colorectal Cancer
35%
Metastasizing
33%
Spleen
33%
Locally Advanced
31%
Heparin
30%
Liver Cirrhosis
30%
Pancreatic Adenocarcinoma
29%
Older Men
28%
Resectable Pancreatic Cancer
28%
High Risk
28%
Diarrhea
28%
Gastrointestinal Tumours
27%
Advanced Hepatocellular Carcinoma
27%
Oncology Patients
27%
Lymphocyte Subsets
26%
Gastrointestinal Malignancies
25%
Monoclonal Antibody
25%
Stomach
25%
Pancreatic Carcinoma
25%
Tumor-bearing Mice
25%
Neurotoxicity
25%
Lymphocytes
25%
Tumor Growth
24%
Peripheral Blood
24%
Palliative Therapy
23%
Budd-Chiari Syndrome
23%
Muscle Force
23%
Ultrasound Examination
23%
Turkish Women
23%
Hypofractionated Radiotherapy
23%
Capecitabine
23%
Lung Tumor
23%
Acute Rejection
23%
Medicine and Dentistry
Diseases
100%
Neoplasm
99%
Thrombosis
59%
Carcinoma
54%
Diagnosis
51%
Cancer
42%
Pancreas Cancer
40%
Echography
39%
Hepatocellular Carcinoma
38%
Sepsis
38%
Liver Cirrhosis
38%
Infection
35%
Adenocarcinoma
35%
Low Molecular Weight Heparin
35%
Tumor Progression
34%
Gastrointestinal Tumor
34%
Surgery
32%
Magnetic Resonance Imaging
31%
Contrast-Enhanced Ultrasound
31%
Radiation Therapy
29%
Heparin
28%
Survival Time
27%
Metastatic Carcinoma
27%
Fluorouracil
26%
Gemcitabine
26%
Symptomatic Treatment
23%
Budd-Chiari Syndrome
23%
Hypofractionated Radiotherapy
23%
Liver Hydatid Cyst
23%
Secretion (Process)
23%
Stomach Carcinoma
23%
Helicobacter Pylori
23%
MALT Lymphoma
23%
Gamma Interferon
23%
Chronic Inflammation
23%
Dysplasia
23%
In Vitro
22%
Pancreas Carcinoma
22%
Bleeding
22%
Differential Diagnosis
21%
Cholangiocarcinoma
20%
Obstructive Jaundice
20%
Infusion
19%
Contrast Medium
18%
Chemoradiotherapy
18%
Continuous Infusion
18%
Edema
17%
Deep Vein Thrombosis
17%
Acute Abdomen
17%
Liver Metastasis
17%